The short answer
Private equity buyers assess seven things in a med spa: transferability of earnings, recurring revenue, provider retention, service mix, patient retention, compliance and structure, and financial quality. The first three tend to set the multiple. The remaining four more often set the terms — escrow, indemnities, earnout structure and timeline. Every one is assessed against evidence rather than description.
Quick answers
Six narrow questions, one sentence each. These catch conversational queries that don’t warrant reading the article. Phrased deliberately differently from the FAQ at the bottom, and not included in the FAQPage schema.
What matters most to a private equity buyer? Whether the earnings continue after you leave — nothing else on the list comes close.
Does my practice need to be a certain size? Size determines which buyer type approaches you rather than whether anyone will, and the tiers are set out in the pillar above.
Do buyers care about my reputation? Only to the extent it is embedded in the brand rather than in you personally, which is a different thing from what most owners mean by reputation.
Will new equipment make my practice more attractive? Not by itself — buyers assess utilisation and outstanding finance, not the equipment list.
How do buyers verify what I tell them? Against system data, bank records and documents, item by item, in a process designed to test rather than to accept.
Can I improve my score before going to market? Six of the seven factors respond within roughly two years; only scale takes longer.
Key takeaways
- Buyers are underwriting cash flow that must exist without you, which reframes every other factor on the list.
- Transferability, recurring revenue and provider retention tend to move the multiple; the remaining four more often move escrow, indemnities and structure.
- Every factor is assessed against evidence — a practice that can demonstrate retention is worth more than an identical practice whose owner describes it accurately but cannot document it.
- Buyers do not pay for potential, for equipment, or for revenue that arrived through discounting.
- Six of the seven factors are improvable inside twenty-four months, which makes this list a preparation plan rather than a verdict.
What is a private equity buyer actually underwriting?
Start here, because it explains everything that follows.
A buyer is not purchasing your practice as it exists with you inside it. They are purchasing an estimate of what it produces without you, under their ownership, financed partly with debt that has to be serviced from those earnings.
Three consequences follow directly, and they account for most of the friction owners experience in a process.
Every patient who books because of you personally is a patient the buyer discounts. Not because your work is not good — because it is not theirs to keep.
Predictable revenue is worth more than equivalent unpredictable revenue. A contracted floor supports leverage in a way that hopeful demand does not.
Anything that cannot be evidenced is treated as absent. Not disputed — absent. A reviewer with limited time and a duty to their client does not adjudicate claims; they verify them or they discount them.
The seven factors below are all expressions of those three ideas.
The three factors that tend to set your multiple
The pillar lists all seven in one table. In practice they do not behave identically — and the difference matters for where you spend a preparation period.
These three most often move the number itself.
Transferability
The share of revenue that survives your departure. It is the largest single lever in medical aesthetics and the hardest to move quickly.
What good looks like: you deliver a minority of treatment revenue, patients see multiple providers as a matter of routine, and the brand rather than a person is what patients name when asked why they come.
How it is verified: revenue by provider from the practice management system, booking distribution across the team, new-patient routing, and what happened to volumes during your last extended absence. If you have never taken one, that absence of evidence is itself the finding.
What weak looks like: heavy concentration in one injector, patients who book by name, marketing built around a founder.
Recurring revenue
Membership and prepaid programmes as a share of the top line.
What good looks like: a meaningful membership share with demonstrable retention, and — increasingly — subscription-shaped programmes inside what is otherwise a per-visit business.
How it is verified: member-level join and cancellation data over several years, calculated independently from your roster rather than accepted from your reporting. Buyers rebuild the churn number themselves.
What weak looks like: a membership count with no cohort history, or members carried on the list after they stopped paying. The second one does more damage than a low number would have, because it puts every other figure you have provided back on the table.
The premium attaching to recurring revenue, with its source, is covered in what a med spa is worth.
Provider retention
Whether the people delivering the revenue will still be there.
What good looks like: tenured injectors, under agreement, on terms enforceable in your state, with the key providers secured through the transition.
How it is verified: employment agreements, tenure records, compensation structures, and direct conversation with providers at the appropriate stage of a process.
What weak looks like: key providers without agreements. This is the factor most likely to produce a heavy earnout rather than a price reduction — a buyer who cannot be confident the team stays will shift consideration into the period where they find out.
The four factors that tend to set your terms
These four matter, and they usually express themselves differently — in escrow size, indemnity scope, earnout structure and how long diligence runs, rather than in the headline multiple.
That distinction is a general pattern rather than a rule; individual buyers weight these differently. But it is a useful way to think about where preparation effort goes.
Service mix
Balance across injectables, devices, and any other lines, and how concentrated the mix is.
Heavy concentration in a single service is a risk regardless of how profitable that service currently is — a device modality facing new competition or an injectable facing pricing pressure both represent the same exposure. Buyers read balance as durability and deliberate diversification as evidence of management quality.
Patient retention
Repeat rate and the size of the genuinely active file, against a definition you can defend.
A large historical database with a small active core describes promotional revenue rather than durable demand, and the booking data shows the difference immediately. Buyers will calculate this themselves; the useful preparation is having several years of it rather than a snapshot.
Compliance and structure
Medical director arrangements, supervision documentation, injector scope, corporate structure, and any management services agreement.
This is the factor most likely to change terms rather than price — a defect here typically produces a specific indemnity carve-out, often uncapped, or a holdback pending remediation, rather than a proportionate reduction. Occasionally it ends a transaction.
The detail is in CPOM and MSO structures.
Financial quality
Whether the books survive a quality of earnings review without restatement.
Weak records do not usually reduce the multiple. They extend the timeline, enlarge the escrow, and — where add-backs fail — reduce the earnings figure the multiple is applied to, which arrives at the same place by a different route.
Evidence, not assertion
The single most useful thing to understand about how buyers assess a practice: they are not evaluating your description of the business. They are evaluating what can be shown.
An owner who reports 85 percent membership retention and an owner who can produce five years of member-level cohort data showing 85 percent retention are in materially different positions. The second is not more honest. They are more bankable, and bankable is what gets priced.
This has a practical implication that runs through every factor above.
| What owners bring | What buyers accept |
|---|---|
| “Our retention is strong” | Member-level join and cancellation history, several years |
| “Patients love the team” | Revenue and booking distribution by provider |
| “That was a one-off cost” | The invoice, the payment record, and the ledger comparison |
| “We’re fully compliant” | Current agreements plus records showing the duties were performed |
| “The devices are well used” | Treatments per device per month |
| “Our staff are staying” | Signed agreements with enforceable terms |
None of the left-hand column is untrue. All of it is unusable.
Building the right-hand column takes time, which is why it belongs to a preparation period rather than to a process — see preparing a med spa for sale.
What buyers do not pay for
Worth stating plainly, because misplaced expectation in these five areas produces more disappointment than any other part of a transaction.
Potential. A market you have not entered, a location you have not opened, a service line you have identified but not launched. Buyers acquire earnings, and they are generally unwilling to pay you for growth they will have to execute themselves.
Equipment. Devices support earnings through utilisation, and earnings are what get multiplied. An underused platform is a fixed cost, and outstanding device finance is settled at closing from the proceeds.
Revenue bought with discounting. A strong year produced by heavy promotion reads as a promotional spike rather than durable demand, and buyers examine gross margin trend alongside revenue trend precisely to detect it.
Your reputation, as you experience it. Reputation embedded in a brand is an asset. Reputation embedded in a person is the transferability problem. The distinction is uncomfortable and it is the one buyers care about.
A single strong year. Consistency across two to three years is worth considerably more than one exceptional one, which invites questions about what changed and whether it holds.
How the scoring becomes an offer
The factors do not produce a number directly. They produce a risk assessment, and the offer is an expression of it.
- Strong across all seven, and the buyer competes on price because they want the asset and expect a clean process.
- Strong on the first three, weaker on the rest, and you typically see a good multiple attached to heavier escrow, tighter indemnities and a longer diligence period.
- Weak on transferability, and consideration moves into the future — earnout, rollover, retention conditions — because the buyer is buying an outcome they cannot yet verify.
- Weak on compliance, and the conversation moves from price to whether the transaction proceeds at all.
Which is why comparing offers on the headline multiple alone tells you very little about what a buyer actually thinks of your practice. The structure is the assessment. How med spa deals are structured covers what those components mean.
A self-assessment you can run this week
Score each factor honestly, out of five, before a buyer does it for you. The exercise takes an afternoon and it is more useful than any valuation calculator.
For each one, ask two questions rather than one:
- How is the practice actually performing on this?
- Could I evidence that today, from records that already exist?
A factor where the answer to the first is strong and the second is weak is not a strong factor. It is a documentation project, and it is usually the fastest improvement available.
Then rank the gaps by lead time rather than by size. Compliance documentation can be fixed in months. Transferability cannot. Starting with the item that takes longest is the whole of the strategy.
Frequently asked questions
What does private equity look for in a med spa? Transferability of earnings above everything — whether the practice performs without you. Then recurring revenue, provider retention, service-mix balance, patient retention, compliance and structure, and financial records that withstand an independent review.
What makes a med spa attractive to buyers? Earnings that continue after the owner leaves, evidenced rather than asserted. A practice that can demonstrate retention, provider tenure and clean documentation is worth more than an identical practice whose owner describes all three accurately but cannot produce the records.
Do private equity buyers only want large practices? No — size determines which type of buyer approaches you rather than whether any will. Individual operators, independent sponsors, regional groups and sponsor-backed platforms target different earnings ranges, as set out in the pillar above.
Will buying new equipment make my med spa more attractive? Rarely on its own. Buyers assess utilisation and remaining useful life rather than the equipment list, and outstanding device finance is settled at closing from the proceeds, reducing what reaches you.
How do buyers check what I have told them? Against system data, bank records and documents, item by item. Membership churn is typically recalculated independently from the roster rather than accepted from seller reporting.
Which of these can I improve before selling? Six of the seven respond within roughly twenty-four months. Only scale takes longer. Transferability is both the highest-value and the slowest, which is why it should be started first.
